Active Biotech AB engages in the development of pharmaceutical products. The firm specializes in the medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease, and various forms of cancer. Its portfolio comprises orally active immunomodulatory molecules as well as antibody-based immunotherapy. The company was founded on June 15, 1982 and is headquartered in Lund, Sweden.

Pharmacia & Upjohn AB is a private company headquartered in Stockholm, Sweden. The firm manufactures pharmaceutical drugs.

Beijing Sanyuan Foods Co., Ltd. engages in the manufacture and sales of dairy products, cold drinks, beverages and food. Its products include liquid milk, fermented milk, milk drinks, milk powder, cheese, ice cream and plant spreads. The company was founded on March 13, 1997 and is headquartered in Beijing, China.

Beijing Zecheng Biotechnology Co., Ltd., established on 2006-03-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of bio-based materials;Sales of bio-based materials;Medical Research and Experimental Development;Mechanical equipment research and development;Domestic trade agent;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Immutrix Therapeutics s is a medical tech company that develops and markets blood cleansing treatment device. The company's product removes inflammatory mediators and toxins from blood using proprietary adsorbents and smart hollow fiber membranes. Immutrix products target and bind molecules (modifiers) of interest in a "dialysis-like" procedure to treat a broad range of medical conditions. The modifiers to be removed are those molecules which cause an undesired immune or pathological response, often referred to as mediators. The company was incorporated in 2009 and is based in Rapid City, South Dakota.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Pharmaceutical concern

Beijing Huaanmaike Biotechnology Co., Ltd., established on 2007-06-26, Business scope includes biotechnology extension services,technology development;Sales of food safety testing products,Equipment,Instrumentation,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals);Import and export;rental instrumentation,Professional setting;Repair instrumentation,Professional setting;Production of food safety testing products.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Beijing Land Bridge Technology Co., Ltd., established on 1998-09-25, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Sell ​​Microbial Products(except medicines),Special equipment for microbial detection,Instrumentation,electronic product,plastic products,Chemical Products(Excluding Class I precursor chemicals and dangerous chemicals);buisness planning;Conference Services;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Sanofi Biotechnology SAS, a subsidiary of Sanofi, is a French company located in Paris that develops biopharmaceutical technology. Mathias Thibault and Laurent Gilhodes are the current co-CEOs of the firm.

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.

Integrated BioTherapeutics is a biotechnology company that focuses on discovering novel vaccines and therapeutics for emerging infectious diseases. Its antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines, and a variety of other product candidates for emerging viruses.